glp-1 drugs semaglutide Decoding Weight Loss Medications Popular obesity drug fails in

This wildly popular drug is a synthetic form of GLP-1 (glucagon-like peptide-1), a hormone that regulates blood sugar and curbs appetite

This novel drug offe

If you are taking medications or have a medical condition, speak with your provider before use

A balanced microbiome environment can help support pathways involved in energy metabolism and appetite regulation

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

GLP-1based therapies are associated with predictable GI adverse effects, most of which are mild to moderate and manageable